Value Bridge — METROHEALTH MEDICAL CENTER
Current $-59M → Target $-33M (+$26.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-58.9M
Current EBITDA
$-32.8M
Target EBITDA
+$26.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$5.9M
Payer Mix Optimization
$14.1M
Cost to Collect Reduction
$4.7M
Clean Claim Improvement
$3.5M
Volume & Rate Growth
$23.5M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-59M to $-33M. The highest-impact lever is Volume & Rate Growth at $9.4M probability-weighted.
IC talking point: "We see $26M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $286M in equity value creation."